ADT Flashcards
action of LHRH agonists
initial surge in LH and testosterone levels in response to LHRH agonists, loss of phasic pituitary stimulation results in plummetting LH levels which causes Leydig cell production of T to drop to castration levels
castration level of T
<50 ng/dl
action of T and DHT on AR
bind to AR in cytoplasm, this complex then translocates to nucleus and binds to androgen response elements in the promotor regions of target genes
T to DHT
passive diffusion through cell membrane to cytoplasms, T conversion to DHT through 5AR, 13 fold more T required if DHT blocked by finasteride for same effect
T free and bound
over half bound to SHBG, 40% bound albumin, 3% remains unbound and is functionally active form
steroid anti androgen
cyproterone acetate
derivative of 17 OH progresterone
suppresses LH release and T production htrough central progesterional inhibtory effects
reduce circulating T elvels, hypogonadal state, loss of libido and ED
severe CVS complication
gynaecomastia in less than 20% of men
non steroidal anti androgen
no anti gonadotropic effects
simply block AR
block normal inhibiting feedback of T, NSAA produce a paradoxic incraease in LH and T
can preserve potentcy
but peripheral conversion of T to oestogren can lead to painful gynaecomastia
bicalutamide
most potent and well tolerated NSAA
long serum half life 6 days
enzalutamide action
AT antagonist
unlike bicalutamide, inhibits AR function by blocking nuclear translocation and DNA binding
Enzalutamide side effects
Diarrhoea
Fatigue
Hot flushes
Seizures <1%
Abiraterone
Inhibitor of 17 alpha hydroxylase
Block conversion of pregnenolone to 17 hydroxypregnenolone
Resulting in excess aldosterone and precursors
Causing a suppression of cortisol with rise in ACTH
Untreated rise in mineralocorticoids leads to hypokalaemia, hypertension and fluid overalls
Co administration of prednisolone suppressed increases in ACTH
Breast symptoms on ADT
75-80% develop gynaecomastia when taking non steroidal anti androgen
Vs 20% on steroidal anti androgen
50% develop pain
Prevention with radiotherapy 8-10Gy to each breast but does lot prevent pain or tenderness
Tamoxifen 20mg od
Hot flushes treatment
Medroxyprogesterone 20mg od ten weeks
Cyproterone acetate 50mg bd for 4 weeks for hot flushes
Cautions enzalutamide
Cautions
History or risk of QT-interval prolongation; history or risk of seizure; recent cardiovascular disease